The centre was inaugurated by Jonty Rhodes, the acclaimed South African cricketer and epilepsy advocate
Aster DM Healthcare has launched its Centre of Excellence for Epilepsy in Bengaluru, a dedicated advanced care centre designed to offer comprehensive diagnosis, advanced treatment, and long-term management for individuals living with epilepsy. The centre, called ‘Aster Global Institute for Advanced Epilepsy Care’, was formally inaugurated by Jonty Rhodes, acclaimed South African cricketer and a global sporting icon, who himself triumphed over epilepsy earlier in life.
The Centre of Excellence, located at Aster CMI Hospital Bengaluru, will integrate highly trained specialists, cutting-edge neurodiagnostic tools, and evidence-based clinical protocols to ensure faster evaluation and more effective treatment for patients. As of now, four of Aster’s Hospitals - Aster CMI, Aster RV, Aster Ramesh, Guntur and Aster MIMS Calicut are jointly involved in this state-of-the-art centre of excellence.
Ramesh Kumar S, Chief Operating Officer – Aster DM Healthcare India, said, “The establishment of Aster Global Institute for Advanced Epilepsy Care marks a significant step forward in our mission to strengthen specialised neurological care across India. At Aster, we are focused on building integrated, patient-centric systems that combine clinical expertise, advanced diagnostics, and innovation. The centre not only enhances our ability to treat complex epilepsy cases but also reinforces our commitment to ensuring that every patient has access to timely, high-quality care, regardless of where they live.”
Dr Ravi Gopal Varma, Director – Aster Global Institute of Neurosciences & Lead Consultant – Neurosurgery, Aster CMI Hospital said, “Epilepsy surgery offers hope to patients who live with the daily uncertainty of seizures. At Aster, we are committed to providing comprehensive evaluation and advanced surgical care so patients can reclaim their lives with confidence and dignity. The launch of this dedicated centre reinforces our mission to make world-class epilepsy treatment accessible to all.”
